Journals / Akdeniz Tıp Dergisi / 2021 / Cilt: 7 - Sayı: 1

Effectiveness of Insulin Pump in Adult Type 1 Diabetes Mellitus Patients

Erişkin Tip 1 Diabetes Mellitus Hastalarında İnsülin Pompasının Etkinliği

Pages
111–118
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found a significant decrease in the HBA1C level by comparing the pre-pump and postpump data in the CSII group 8.8% ± 1.4 and 7.8% ± 1.2 , respectively, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study is to evaluate the effectiveness of continuous subcutaneous insulin infusion CSII treatment with the insulin pump in type 1 diabetes mellitus DM patients.Material and Methods: We retrospectively analyzed the data of patients who were being followed up with the diagnosis of type 1 DM and receiving continuous subcutaneous insulin infusion treatment with insulin pump CSII group , and compared the pre-pump and post-pump data.
📊
Key Findings & Data:In addition, we formed a group of type 1 DM patients who received multiple daily insulin injection MDII treatment and retrospectively analyzed the data.
💡
Conclusion & Impact:We found a significant decrease in the HBA1C level by comparing the pre-pump and postpump data in the CSII group 8.8% ± 1.4 and 7.8% ± 1.2 , respectively, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İnsülin pompası · İntensif insülin tedavisi · Sürekli cilt altı insülin infüzyonu

Abstract

Objective: The aim of the study is to evaluate the effectiveness of continuous subcutaneous insulin infusion CSII treatment with the insulin pump in type 1 diabetes mellitus DM patients.Material and Methods: We retrospectively analyzed the data of patients who were being followed up with the diagnosis of type 1 DM and receiving continuous subcutaneous insulin infusion treatment with insulin pump CSII group , and compared the pre-pump and post-pump data. In addition, we formed a group of type 1 DM patients who received multiple daily insulin injection MDII treatment and retrospectively analyzed the data. The data of the CSII group and the MDII group were also compared.Results: 94 patients 49 in the CSII group and 45 in the MDII group were included in the study in total. We found a significant decrease in the HBA1C level by comparing the pre-pump and postpump data in the CSII group 8.8% ± 1.4 and 7.8% ± 1.2 , respectively, p

Özet

Amaç: Bu çalışmanın amacı, tip 1 diabetes mellitus DM hastalarında insülin pompası ile sürekli cilt altı insülin infüzyonu SCİİ tedavisinin etkinliğini değerlendirmektir.Gereç ve Yöntemler: Tip 1 DM tanısı ile izlenen ve insülin pompası ile sürekli cilt altı insülin infüzyonu yapılan hastaların SCİİ grubu verileri retrospektif olarak incelenerek hastaların pompa öncesi ve sonrası verileri karşılaştırıldı. Ek olarak; çoklu insülin enjeksiyonu ÇİE tedavisi alan tip 1 DM hastalarından bir grup ÇİE grubu daha oluşturularak bu hastaların da verileri retrospektif olarak incelendi ve SCİİ grubu ile ÇİE grubunun verileri karşılaştırıldı.Bulgular: Çalışmaya 49’u SCİİ grubunda, 45’i ise ÇİE grubunda olmak üzere toplam 94 hasta alındı. SCİİ grubunda, pompa tedavisi sonrasında pompa öncesine göre HBA1C düzeyinde anlamlı düzeyde bir azalma saptandı Sırası ile %8,8 ±1,4 ve %7,8 ±1,2 p

🔖

Cite This Article

YILMAZ, N., SARI, R., BALCI, M. K., DOĞRUEL, H., DALKIRAN, Ş. (2022). Effectiveness of Insulin Pump in Adult Type 1 Diabetes Mellitus Patients. Akdeniz Tıp Dergisi, Cilt: 7 - Sayı: 1, 111–118. https://ajindex.com/articles/434222

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Almogbel E. Impact of insulin pump therapy on glycemic control among adult Saudi type-1 diabetic patients. An interview-based case-control study. J Family Med Prim Care 2020; 9:1013-9.
  2. Melmed S, Koenig R, Rosen C, Auchus R, Goldfine A. Williams textbook of endocrinology, 14th Edition,
  3. E-Book, Elsevier, 2020.
  4. Abaci A, Atas A, Unuvar T, Demir K, Bober E, Büyük- gebiz A. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: A single-center experience from Turkey. J Pediatr Endocrinol Metab 2009; 22:539-46. Association AD. 15. Diabetes care in the hospital: Stan- dards of medical care in diabetes-2020. Diabetes Care 2020; 43:193-202.
  5. Cander S, Kıyıcı S, Deligönül A, Gül ÖÖ, Ünal OK, Sakallı M, Tuncel E, İmamoğlu Ş. Cilt altı insülin infüz- yon tedavisinin tip 1 diyabetik hastalarda tedavi etkinliği. Turkish Journal of Endocrinology & Metabolism 2010; 14:80-4.
  6. White N, Cleary P, Dahms W, Goldstein D, Malone J, Tamborlane W. Diabetes Control and Complications T rial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) research group. Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the diabetes control and complications trial (DCCT). J Pediatr 2001; 139:804-12. Association AD. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the diabe- tes control and complications trial cohort. Diabetes Care 1999; 22:99-111.
  7. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB. Comparative effectiveness and safety of methods of insu- lin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012; 157:336-47.
  8. Al HAA, Robert AA, Al MA. Dawish. Skin-related comp- lications among adolescents with type 1 diabetes using insulin pump therapy. Clin Med Insights Endocrinol Diabetes 2018; 11:1-5
  9. Ross P, Milburn J, Reith D, Wiltshire E, Wheeler B. Clinical review: Insulin pump-associated adverse events in adults and children. Acta Diabetol 2015; 52:1017-24.
  10. Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC. Diabetes management in the new millen- nium using insulin pump therapy. Diabetes Metab Res Rev Suppl 2002; 1:14-20.
  11. Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U, Boettcher C, Kapellen T, Rosen- ba